先看重點
彙總41項研究後,使用消費級活動追蹤器的介入專案可增加學齡兒童的每日步數(d = 0.612,95%置信區間0.477-0.746)和中高強度活動(d = 0.220),但久坐行為沒有改善(d = 0.172,方向不利)。證據確定性為低至中等,且不少納入研究並非隨機設計。
證據類型
證據回顧
解讀依據
公開摘要
閱讀重點
方法與適用範圍
研究在問什麼
追蹤器常被用於促進兒童活動的專案,但總體效果以及哪類專案更有效並不清楚。作者評估了追蹤器專案對錶面健康兒童客觀測量的步數、活動量和久坐時間的影響,並比較了不同亞組。
研究對象與方法
系統綜述與統合分析(PROSPERO CRD42020222363),納入採用消費級活動追蹤器的介入專案,物件為18歲以下表面健康的兒童,對照為基線和/或對照組,設計包括前實驗、準實驗和真實驗。檢索8個資料庫至2020年12月,另用4種補充檢索方式;偏倚風險採用Cochrane偏倚風險工具2。系統綜述納入45項研究(5,620名獨立參與者,平均年齡12.85 ± 2.84歲),統合分析納入41項;專案平均時長11.78 ± 13.17週。用隨機效應模型計算Cohen's d及95%置信區間。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1每日總步數有中等程度增加(d = 0.612,95%置信區間0.477-0.746)。
- 2每日中高強度身體活動小幅增加(d = 0.220,95%置信區間0.134-0.307),總身體活動量增加幅度很小(d = 0.151,95%置信區間0.038-0.264)。
- 3久坐行為出現了幅度很小的不利效應(d = 0.172,95%置信區間0.039-0.305),即久坐時間並未減少。
- 4女孩的步數和中高強度活動增幅更大,缺乏運動的兒童步數增幅更大(p = 0.003-0.044)。
- 5帶有教育諮詢和/或目標設定的專案、策略更多的專案,步數增加更明顯;腕戴式追蹤器在改善中高強度活動方面優於腰戴式(p = 0.001-0.021)。
限制與不確定性
- 1作者將證據確定性評為低至中等。
- 2納入設計從前實驗到隨機試驗不等,許多研究缺少有力的對照比較。
- 3專案時長差異很大(平均11.78 ± 13.17週),按性別、佩戴位置、策略的亞組比較屬於研究間比較,並非隨機分配。
- 4本解讀僅基於摘要。
日常健康啟示
以追蹤器為基礎的專案,尤其是配合目標設定和指導,似乎能讓孩子多走路,但高強度活動的增幅較小,久坐時間並未改善。單靠一個追蹤器恐怕不夠,目標和成年人的支援似乎也很關鍵。
如何連結自己的資料
給孩子用追蹤器時,步數是效果最明確的指標,建議用同一裝置、同一佩戴位置比較每週平均值。把追蹤器當作設定目標的提示工具,而不是精確衡量強度或久坐時間的工具。
如何理解這類證據
先看納入了哪些設計、文獻搜尋與偏誤評估如何完成,以及搜尋截止日期;發表新不代表底層證據都是最新的。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
The popularity of consumer-wearable activity trackers has led the scientific community to conduct an increasing number of intervention studies integrating them to promote physical activity (PA) and to reduce sedentary behavior (SB) levels among school-aged children. Therefore, the aim of the present study was to estimate the effects of consumer-wearable activity tracker-based programs on daily objectively measured PA and SB among apparently healthy school-aged children, as well as to compare the influence of participants' and programs' characteristics.
Methods
Eligibility criteria were: (1) participants: apparently healthy school-aged children (< 18 years old); (2) intervention: aimed to promote PA and/or to reduce SB incorporating consumer-wearable activity trackers; (3) comparator: baseline measurements and/or a control/traditional group; (4) outcomes: objectively measured daily PA and/or SB levels; (5) study design: pre-experimental, quasi-experimental, and true-experimental trials. Relevant studies were searched from eight databases up to December 2020, as well as from four alternative modes of searching. Based on the Cochrane Risk-of-bias tool 2, the risk of bias was assessed following four domains: (1) randomization process; (2) missing outcome data; (3) measurement of the outcomes; and (4) selection of the reported results. Based on a comprehensive systematic review, meta-analyses of the Cohen's standardized mean difference (d) and 95% confidence interval (CI) with a random-effects model were conducted to estimate the overall effects, as well as the within- and between-study subgroups analyses effects, of the programs on daily total steps, moderate-to-vigorous PA (MVPA), total PA and SB.
Results
Forty-four publications (i.e., 45 studies) were included in the systematic review (5,620 unique participants; mean age = 12.85 ± 2.84 years) and 40 publications (i.e., 41 studies) in the meta-analysis. Programs had a mean length of 11.78 ± 13.17 weeks and most used a waist-worn consumer-wearable activity tracker (77.78% waist-worn; 22.22% wrist-worn). Programs characteristics were: goal-setting strategies (64.06%); participants' logbooks (56.25%); counseling sessions (62.50%); reminders (28.13%); motivational strategies (42.19%); and exercise routine (17.19%). Results showed a statistically significant moderate favorable effect on daily total steps (d = 0.612, 95% CI 0.477-0.746), small favorable effect on daily MVPA (d = 0.220, 95% CI 0.134-0.307), trivial favorable effect on daily total PA (d = 0.151, 95% CI 0.038-0.264) and trivial unfavorable effect on daily SB (d = 0.172, 95% CI 0.039-0.305). Subgroups analyses showed a higher effect for daily total steps and daily MVPA levels in females and the physically inactive for daily total steps (p = 0.003-0.044). Programs with educational counseling and/or goal-setting strategies, as well as a greater number of strategies, were more effective for improving children's daily total steps, and wrist-worn activity trackers were more effective than waist-worn trackers for improving their daily MVPA levels (p = 0.001-0.021).
Conclusions
Consumer-wearable activity tracker-based programs seem to be effective in promoting school-aged children's daily total steps and MVPA levels, especially for females and those that are physically inactive. These programs should include specific goal-setting, educational counseling, and wrist-worn trackers as especially effective strategies. However, due to the certainty of evidence being from "low" to "moderate", future well-designed primary research studies about the topic are needed.
Prospero
CRD42020222363.
來源與署名
Effects of Consumer-Wearable Activity Tracker-Based Programs on Objectively Measured Daily Physical Activity and Sedentary Behavior Among School-Aged Children: A Systematic Review and Meta-analysis.
Casado-Robles C, Viciana J, Guijarro-Romero S, Mayorga-Vega D.
Sports medicine - open · 2022-01-31
DOI: 10.1186/s40798-021-00407-6 ↗PubMed · 35099630 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
加速度計處理方法不同,身體活動與中風、心肌梗死的關聯曲線也不同
在英國生物銀行中,基線無心血管疾病的90237名成年人追蹤至2022年12月,共發生1298例中風和2031例心肌梗死;中高強度身體活動(MVPA)與這兩種結局的關聯曲線形狀,取決於加速度計資料的處理方法。就中風而言,只有機器學習法得到直線下降的風險;就心肌梗死而言,機器學習法和LFENMO法呈曲線下降,活動計數法呈直線下降。摘要沒有給出風險比,只能說明不同方法的結論不一致,不能說明哪種方法更正確,而且這些只是觀察性關聯。
Preventive Medicine
智慧手錶資料能當「證人」嗎:心率驗證得最充分,其餘證據參差
一項圍繞數字取證展開的系統評價和統合分析,梳理了四大主流品牌智慧手錶的驗證研究,發現心率是研究最多、也最準確的指標。步數、距離、能量消耗、活動分類和睡眠的驗證不夠一致,結果因品牌、方案和報告方式而異。摘要沒有給出彙總資料,且多數研究是在健康族群中、於實驗室內完成的,所以無法說明某一塊手錶對某個人在日常生活中的表現。
Forensic Science International
活動追蹤器:每天多走約1800步,對其他健康指標影響較小
這項傘形綜述彙總了39篇系統評價和統合分析,涉及163992名參與者;結果顯示使用活動追蹤器與身體活動增加相關(標準化均數差SMD為0.3–0.6),相當於每天多走約1800步、多步行40分鐘,體重減輕約1公斤。對血壓、膽固醇、糖化血紅蛋白、生活質量和疼痛的影響通常很小,且多數不顯著。摘要沒有說明這些專案裡追蹤器還搭配了什麼,也沒有說明各評價之間重疊多少,因此不能把效果完全歸功於裝置本身。
The Lancet Digital Health
七款睡眠追蹤裝置:識別睡著很準,識別醒著和睡眠分期較差
在睡眠實驗室裡,34名健康的年輕成年人連續三晚佩戴七款消費級睡眠追蹤裝置中的若干款。與多導睡眠監測相比,所有裝置識別睡眠都很準(靈敏度均不低於0.93),但識別清醒較差(特異度0.18–0.54),七款中有五款與研究用活動記錄儀(特異度0.39)持平或更好;睡眠分期的估計結果不穩定。受試者是18至35歲的健康成年人,臥床時間固定為8小時,每款裝置只在其中11至20人身上測試,因此對有睡眠問題的人幾乎沒有參考價值。
Sleep

